1. Home
  2. DERM vs CAF Comparison

DERM vs CAF Comparison

Compare DERM & CAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

N/A

Current Price

$4.98

Market Cap

190.3M

Sector

Health Care

ML Signal

N/A

Logo Morgan Stanley China A Share Fund Inc.

CAF

Morgan Stanley China A Share Fund Inc.

N/A

Current Price

$16.16

Market Cap

224.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
DERM
CAF
Founded
2014
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
190.3M
224.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DERM
CAF
Price
$4.98
$16.16
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $13.75
N/A
AVG Volume (30 Days)
★ 178.1K
11.3K
Earning Date
11-11-2026
01-01-0001
Dividend Yield
N/A
★ 1.02%
EPS Growth
★ 34.72
N/A
EPS
N/A
★ N/A
Revenue
★ $61,858,000.00
N/A
Revenue This Year
$25.29
N/A
Revenue Next Year
$50.00
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 10.20
N/A
52 Week Low
$4.31
$15.60
52 Week High
$9.56
$21.41

Technical Indicators

Market Signals
Indicator
DERM
CAF
Relative Strength Index (RSI) 34.52 26.50
Support Level $4.84 N/A
Resistance Level $5.50 $18.47
Average True Range (ATR) 0.34 0.35
MACD -0.03 -0.06
Stochastic Oscillator 15.91 2.44

Price Performance

Historical Comparison
DERM
CAF

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

About CAF Morgan Stanley China A Share Fund Inc.

Morgan Stanley China A Share Fund Inc is the United States based non-diversified, closed-end management investment company. Its investment objective is to seek capital growth by investing a majority of its assets in A-shares of Chinese companies listed on the Shanghai and Shenzhen Stock Exchanges. Its portfolio of investments consists of investment in different sectors such as the aerospace and defense, banks, automobiles, household durables, media, pharmaceuticals, software and other sectors.

Share on Social Networks: